Nusinersen versus sham control in later-onset spinal muscular atrophy
<p><strong>Background:</strong><br /> Nusinersen is an antisense oligonucleotide drug that modulates pre–messenger RNA splicing of the survival motor neuron 2 (SMN2) gene. It has been developed for the treatment of spinal muscular atrophy (SMA).</p><br /> <p&g...
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Massachusetts Medical Society
2018
|